• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个全州范围的惩教系统中,接受阿片类物质使用障碍药物治疗后卫生服务利用情况的变化

Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System.

作者信息

Howell Benjamin A, Martin Rosemarie A, Lebeau Rebecca, Truong Ashley Q, Wang Emily A, Rich Josiah D, Clarke Jennifer G

机构信息

Benjamin A. Howell (

Rosemarie A. Martin is an associate professor in the Department of Behavioral and Social Sciences, Brown University School of Public Health, in Providence, Rhode Island.

出版信息

Health Aff (Millwood). 2021 Aug;40(8):1304-1311. doi: 10.1377/hlthaff.2020.02156.

DOI:10.1377/hlthaff.2020.02156
PMID:34339247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9036835/
Abstract

To decrease opioid overdose mortality, prisons and jails in the US are increasingly offering medications for opioid use disorder (OUD) to incarcerated people. It is unknown how receipt of these medications in a correctional setting affects health services use after release. In this article we analyze changes in postrelease health care use after the implementation of a statewide medications for OUD program in the unified jail and prison system of the Rhode Island Department of Corrections. Using Medicaid claims data, we examined individual health care use in the community before and after receipt of medications for OUD while incarcerated. We found that inpatient admissions did not change, emergency department visits decreased, and both nonacute outpatient services and pharmacy claims increased after people received medications for OUD while incarcerated. There was no change in total health care costs paid by Medicaid. Our findings provide evidence that people's use of health care services paid for by Medicaid did not increase after they started medications for OUD in correctional settings. Given the frequent interaction of people with OUD with the criminal justice system, offering evidence-based treatment of OUD in correctional settings is an important opportunity to initiate addiction treatment.

摘要

为降低阿片类药物过量致死率,美国的监狱正越来越多地为被监禁者提供治疗阿片类药物使用障碍(OUD)的药物。在惩教环境中接受这些药物如何影响释放后的医疗服务使用情况尚不清楚。在本文中,我们分析了罗德岛惩教部统一监狱系统中实施全州范围的OUD药物项目后释放后医疗保健使用情况的变化。利用医疗补助索赔数据,我们研究了被监禁者在接受OUD药物治疗前后在社区中的个人医疗保健使用情况。我们发现,住院人数没有变化,急诊就诊次数减少,被监禁者接受OUD药物治疗后,非急性门诊服务和药房索赔均增加。医疗补助支付的总医疗费用没有变化。我们的研究结果表明,在惩教环境中开始接受OUD药物治疗后,人们使用由医疗补助支付的医疗服务并没有增加。鉴于患有OUD的人与刑事司法系统的频繁互动,在惩教环境中提供基于证据的OUD治疗是启动成瘾治疗的重要契机。

相似文献

1
Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System.在一个全州范围的惩教系统中,接受阿片类物质使用障碍药物治疗后卫生服务利用情况的变化
Health Aff (Millwood). 2021 Aug;40(8):1304-1311. doi: 10.1377/hlthaff.2020.02156.
2
The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.在全州范围内的惩教系统中实施阿片类药物使用障碍治疗药物和 COVID-19 对治疗参与度、释放后继续治疗和药物过量的影响。
J Subst Use Addict Treat. 2023 Sep;152:209103. doi: 10.1016/j.josat.2023.209103. Epub 2023 Jun 11.
3
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.扩大监狱中阿片类药物使用障碍(MOUD)药物的获取途径:一项综合项目评估。
J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9.
4
Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails.评估在美国监狱中广泛采用阿片类药物使用障碍筛查和药物治疗的影响。
Drug Alcohol Depend. 2020 Mar 1;208:107858. doi: 10.1016/j.drugalcdep.2020.107858. Epub 2020 Jan 18.
5
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).马萨诸塞州司法社区阿片类药物创新网络(MassJCOIN)。
J Subst Abuse Treat. 2021 Sep;128:108275. doi: 10.1016/j.jsat.2021.108275. Epub 2021 Jan 8.
6
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.监禁人员中与阿片类药物相关的治疗、干预措施和结果:系统评价。
PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec.
7
Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States.美沙酮维持治疗在美墨边境的应用及挑战
PLoS Med. 2020 May 18;17(5):e1003119. doi: 10.1371/journal.pmed.1003119. eCollection 2020 May.
8
An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.对被监禁者阿片类药物使用障碍(MOUD)药物治疗的伦理分析。
Subst Abus. 2020;41(2):150-154. doi: 10.1080/08897077.2019.1695706. Epub 2019 Dec 4.
9
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.阿片类物质使用障碍的监狱内药物治疗与社区持续治疗之间的照护过渡:一项回顾性队列研究。
Drug Alcohol Depend. 2024 Aug 1;261:111377. doi: 10.1016/j.drugalcdep.2024.111377. Epub 2024 Jun 24.
10
Medicaid Expansion Increased Medications For Opioid Use Disorder Among Adults Referred By Criminal Justice Agencies.医疗补助扩大计划增加了通过刑事司法机构转介的成年人的阿片类药物使用障碍药物治疗。
Health Aff (Millwood). 2021 Apr;40(4):562-570. doi: 10.1377/hlthaff.2020.01251.

引用本文的文献

1
Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial.丁丙诺啡-纳洛酮与纳曲酮长效制剂治疗有和无刑事法律问题的阿片类物质使用障碍:X:BOT 随机对照试验的二次分析。
J Subst Use Addict Treat. 2024 Sep;164:209438. doi: 10.1016/j.josat.2024.209438. Epub 2024 Jun 8.
2
Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.马来西亚的研究:出狱时较高的美沙酮剂量可预测与维持治疗的关联,有利于 HIV 和阿片类药物使用障碍者过渡到社区。
Int J Drug Policy. 2024 Apr;126:104369. doi: 10.1016/j.drugpo.2024.104369. Epub 2024 Mar 14.
3
Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis.基于监狱的阿片类药物使用障碍治疗以及释放后的再次监禁模式和急性护理使用情况:一项序列分析。
J Subst Use Addict Treat. 2024 Mar;158:209254. doi: 10.1016/j.josat.2023.209254. Epub 2023 Dec 10.
4
Substance Use Disorders, Mental Illness, and Health Care Utilization Among Adults With Recent Criminal Legal Involvement.物质使用障碍、精神疾病与近期有刑事法律问题的成年人的医疗保健利用。
Psychiatr Serv. 2024 Mar 1;75(3):221-227. doi: 10.1176/appi.ps.20220491. Epub 2023 Sep 7.
5
The Associations Between Medical and Mental Health Conditions and Health Care Utilization in US Adults with Past-Year Criminal Legal Involvement.过去一年有刑事法律问题的美国成年人中,医疗和心理健康状况与医疗保健利用之间的关联。
J Gen Intern Med. 2024 Jan;39(1):77-83. doi: 10.1007/s11606-023-08362-6. Epub 2023 Aug 30.
6
Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder.药物治疗对阿片类药物使用障碍患者医疗保健利用的影响。
Psychiatr Serv. 2023 Dec 1;74(12):1227-1233. doi: 10.1176/appi.ps.20220549. Epub 2023 Jun 20.
7
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study.在从监狱获释后,近期有注射吸毒史的男性使用阿片类激动剂治疗是否与更广泛的初级保健使用相关?一项前瞻性队列研究。
Harm Reduct J. 2023 Mar 28;20(1):42. doi: 10.1186/s12954-023-00773-2.
8
Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia.澳大利亚维多利亚州监狱释放后阿片类激动剂治疗保留和急诊医疗保健接触的前瞻性研究。
Emerg Med J. 2023 May;40(5):347-354. doi: 10.1136/emermed-2022-212755. Epub 2023 Feb 9.

本文引用的文献

1
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.药物和阿片类药物相关过量死亡 - 美国,2017-2018 年。
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.
2
Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program.罗得岛惩教署综合药物辅助治疗计划参与者的释放后治疗参与度。
Prev Med. 2019 Nov;128:105766. doi: 10.1016/j.ypmed.2019.105766. Epub 2019 Jul 4.
3
Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use.健康、多种物质使用与不同程度阿片类药物使用的成年人的刑事司法涉入。
JAMA Netw Open. 2018 Jul 6;1(3):e180558. doi: 10.1001/jamanetworkopen.2018.0558.
4
The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System.美国全州惩教系统首个阿片类药物使用障碍综合项目。
Am J Public Health. 2018 Oct;108(10):1323-1325. doi: 10.2105/AJPH.2018.304666.
5
Opioid Overdose Mortality Among Former North Carolina Inmates: 2000-2015.北卡罗来纳州前囚犯阿片类药物过量死亡率:2000-2015 年。
Am J Public Health. 2018 Sep;108(9):1207-1213. doi: 10.2105/AJPH.2018.304514. Epub 2018 Jul 19.
6
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.在全州监狱系统实施药物成瘾治疗后,监禁后的致命过量。
JAMA Psychiatry. 2018 Apr 1;75(4):405-407. doi: 10.1001/jamapsychiatry.2017.4614.
7
Healthcare utilization and costs associated with treatment for opioid dependence.与阿片类药物依赖治疗相关的医疗保健利用情况和费用。
J Med Econ. 2018 Apr;21(4):406-415. doi: 10.1080/13696998.2018.1427101. Epub 2018 Feb 1.
8
The Economic Burden of Opioid Abuse: Updated Findings.阿片类药物滥用的经济负担:最新发现。
J Manag Care Spec Pharm. 2017 Apr;23(4):427-445. doi: 10.18553/jmcp.2017.16265. Epub 2016 Dec 30.
9
Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001-12.2001-2012 年美国因海洛因和处方类阿片类药物过量导致的住院治疗、费用和结果。
Addiction. 2017 Sep;112(9):1558-1564. doi: 10.1111/add.13795. Epub 2017 Mar 16.
10
Identification of Emergency Department Visits in Medicare Administrative Claims: Approaches and Implications.医疗保险行政索赔中急诊科就诊情况的识别:方法与影响
Acad Emerg Med. 2017 Apr;24(4):422-431. doi: 10.1111/acem.13140. Epub 2017 Mar 17.